APO Research
Talk to an analyst

APO RESEARCH · REPORT

Celiac Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Celiac Drugs Market Analysis and Forecast 2026-2032

22 December 2025208 pages

Choose your research edition.

Industry ResearchCeliac Drugs Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Celiac Drugs Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Celiac Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Celiac Drugs Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Celiac Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Celiac Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Celiac Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Celiac Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Celiac Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Celiac Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Celiac Drugs include Johnson & Johnson, Novartis, Merck, Biogen, Bayer, Amgen, LFB Group, Kedrion Biopharma and Innovate Biopharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Celiac Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Celiac Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Celiac Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Celiac Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Celiac Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Celiac Drugs sales, projected growth trends, production technology, application and end-user industry.

Celiac Drugs Segment by Company

Johnson & Johnson

Novartis

Merck

Biogen

Bayer

Amgen

LFB Group

Kedrion Biopharma

Innovate Biopharmaceuticals

ImmusanT

Immunomedics

ImmunogenX

F Hoffmann-La Roche

Celimmune

Celgene

Bristol-Myers Squibb

Biotest

BioLineRx

Anthera Pharmaceuticals

ADMA Biologics

Celiac Drugs Segment by Type

First Line Of Treatment

Second Line Of Treatment

Celiac Drugs Segment by Application

Women

Men

Children

Celiac Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Celiac Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Celiac Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Celiac Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Celiac Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Celiac Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Celiac Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Celiac Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. First Line Of Treatment Major Manufacturers Table 3. Second Line Of Treatment Major Manufacturers Table 4. Global Celiac Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Women Major Manufacturers Table 6. Men Major Manufacturers Table 7. Children Major Manufacturers Table 8. Celiac Drugs Industry Trends Table 9. Celiac Drugs Industry Drivers Table 10. Celiac Drugs Industry Opportunities and Challenges Table 11. Celiac Drugs Industry Restraints Table 12. Global Celiac Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Celiac Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Celiac Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Celiac Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Celiac Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Celiac Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Celiac Drugs Sales by Region (2021-2026) & (k units) Table 19. Global Celiac Drugs Sales by Region (2027-2032) & (k units) Table 20. Global Celiac Drugs Sales Market Share by Region (2021-2026) Table 21. Global Celiac Drugs Sales Market Share by Region (2027-2032) Table 22. Global Celiac Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Celiac Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Celiac Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Celiac Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Celiac Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Celiac Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Celiac Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Celiac Drugs Manufacturers, Product Type & Application Table 30. Global Celiac Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Celiac Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Celiac Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Celiac Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Celiac Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Celiac Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Celiac Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Celiac Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Celiac Drugs Sales by Type (2021-2026) & (k units) Table 40. Global Celiac Drugs Sales by Type (2027-2032) & (k units) Table 41. Global Celiac Drugs Sales Market Share by Type (2021-2026) Table 42. Global Celiac Drugs Sales Market Share by Type (2027-2032) Table 43. Global Celiac Drugs Price by Type (2021-2026) & (US$/unit) Table 44. Global Celiac Drugs Price by Type (2027-2032) & (US$/unit) Table 45. Global Celiac Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Celiac Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Celiac Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Celiac Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Celiac Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Celiac Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Celiac Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Celiac Drugs Sales by Application (2027-2032) & (k units) Table 53. Global Celiac Drugs Sales Market Share by Application (2021-2026) Table 54. Global Celiac Drugs Sales Market Share by Application (2027-2032) Table 55. Global Celiac Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Celiac Drugs Price by Application (2027-2032) & (US$/unit) Table 57. Johnson & Johnson Company Information Table 58. Johnson & Johnson Business Overview Table 59. Johnson & Johnson Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Johnson & Johnson Celiac Drugs Product Portfolio Table 61. Johnson & Johnson Recent Development Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Novartis Celiac Drugs Product Portfolio Table 66. Novartis Recent Development Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Merck Celiac Drugs Product Portfolio Table 71. Merck Recent Development Table 72. Biogen Company Information Table 73. Biogen Business Overview Table 74. Biogen Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Biogen Celiac Drugs Product Portfolio Table 76. Biogen Recent Development Table 77. Bayer Company Information Table 78. Bayer Business Overview Table 79. Bayer Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Bayer Celiac Drugs Product Portfolio Table 81. Bayer Recent Development Table 82. Amgen Company Information Table 83. Amgen Business Overview Table 84. Amgen Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Amgen Celiac Drugs Product Portfolio Table 86. Amgen Recent Development Table 87. LFB Group Company Information Table 88. LFB Group Business Overview Table 89. LFB Group Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. LFB Group Celiac Drugs Product Portfolio Table 91. LFB Group Recent Development Table 92. Kedrion Biopharma Company Information Table 93. Kedrion Biopharma Business Overview Table 94. Kedrion Biopharma Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Kedrion Biopharma Celiac Drugs Product Portfolio Table 96. Kedrion Biopharma Recent Development Table 97. Innovate Biopharmaceuticals Company Information Table 98. Innovate Biopharmaceuticals Business Overview Table 99. Innovate Biopharmaceuticals Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Innovate Biopharmaceuticals Celiac Drugs Product Portfolio Table 101. Innovate Biopharmaceuticals Recent Development Table 102. ImmusanT Company Information Table 103. ImmusanT Business Overview Table 104. ImmusanT Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. ImmusanT Celiac Drugs Product Portfolio Table 106. ImmusanT Recent Development Table 107. Immunomedics Company Information Table 108. Immunomedics Business Overview Table 109. Immunomedics Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Immunomedics Celiac Drugs Product Portfolio Table 111. Immunomedics Recent Development Table 112. ImmunogenX Company Information Table 113. ImmunogenX Business Overview Table 114. ImmunogenX Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. ImmunogenX Celiac Drugs Product Portfolio Table 116. ImmunogenX Recent Development Table 117. F Hoffmann-La Roche Company Information Table 118. F Hoffmann-La Roche Business Overview Table 119. F Hoffmann-La Roche Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. F Hoffmann-La Roche Celiac Drugs Product Portfolio Table 121. F Hoffmann-La Roche Recent Development Table 122. Celimmune Company Information Table 123. Celimmune Business Overview Table 124. Celimmune Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Celimmune Celiac Drugs Product Portfolio Table 126. Celimmune Recent Development Table 127. Celgene Company Information Table 128. Celgene Business Overview Table 129. Celgene Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Celgene Celiac Drugs Product Portfolio Table 131. Celgene Recent Development Table 132. Bristol-Myers Squibb Company Information Table 133. Bristol-Myers Squibb Business Overview Table 134. Bristol-Myers Squibb Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Bristol-Myers Squibb Celiac Drugs Product Portfolio Table 136. Bristol-Myers Squibb Recent Development Table 137. Biotest Company Information Table 138. Biotest Business Overview Table 139. Biotest Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Biotest Celiac Drugs Product Portfolio Table 141. Biotest Recent Development Table 142. BioLineRx Company Information Table 143. BioLineRx Business Overview Table 144. BioLineRx Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. BioLineRx Celiac Drugs Product Portfolio Table 146. BioLineRx Recent Development Table 147. Anthera Pharmaceuticals Company Information Table 148. Anthera Pharmaceuticals Business Overview Table 149. Anthera Pharmaceuticals Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 150. Anthera Pharmaceuticals Celiac Drugs Product Portfolio Table 151. Anthera Pharmaceuticals Recent Development Table 152. ADMA Biologics Company Information Table 153. ADMA Biologics Business Overview Table 154. ADMA Biologics Celiac Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 155. ADMA Biologics Celiac Drugs Product Portfolio Table 156. ADMA Biologics Recent Development Table 157. North America Celiac Drugs Revenue by Type (2021-2026) & (US$ Million) Table 158. North America Celiac Drugs Revenue by Type (2027-2032) & (US$ Million) Table 159. North America Celiac Drugs Sales by Type (2021-2026) & (k units) Table 160. North America Celiac Drugs Sales by Type (2027-2032) & (k units) Table 161. North America Celiac Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 162. North America Celiac Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 163. North America Celiac Drugs Revenue by Application (2021-2026) & (US$ Million) Table 164. North America Celiac Drugs Revenue by Application (2027-2032) & (US$ Million) Table 165. North America Celiac Drugs Sales by Application (2021-2026) & (k units) Table 166. North America Celiac Drugs Sales by Application (2027-2032) & (k units) Table 167. North America Celiac Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 168. North America Celiac Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 169. North America Celiac Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. North America Celiac Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. North America Celiac Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. North America Celiac Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 173. North America Celiac Drugs Sales by Country (2021-2026) & (k units) Table 174. North America Celiac Drugs Sales by Country (2027-2032) & (k units) Table 175. North America Celiac Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 176. North America Celiac Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 177. United States Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 178. Canada Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 179. Mexico Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 180. Europe Celiac Drugs Revenue by Type (2021-2026) & (US$ Million) Table 181. Europe Celiac Drugs Revenue by Type (2027-2032) & (US$ Million) Table 182. Europe Celiac Drugs Sales by Type (2021-2026) & (k units) Table 183. Europe Celiac Drugs Sales by Type (2027-2032) & (k units) Table 184. Europe Celiac Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 185. Europe Celiac Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 186. Europe Celiac Drugs Revenue by Application (2021-2026) & (US$ Million) Table 187. Europe Celiac Drugs Revenue by Application (2027-2032) & (US$ Million) Table 188. Europe Celiac Drugs Sales by Application (2021-2026) & (k units) Table 189. Europe Celiac Drugs Sales by Application (2027-2032) & (k units) Table 190. Europe Celiac Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 191. Europe Celiac Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 192. Europe Celiac Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Europe Celiac Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Europe Celiac Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Europe Celiac Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 196. Europe Celiac Drugs Sales by Country (2021-2026) & (k units) Table 197. Europe Celiac Drugs Sales by Country (2027-2032) & (k units) Table 198. Europe Celiac Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 199. Europe Celiac Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 200. Germany Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 201. France Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 202. U.K. Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 203. Italy Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 204. Russia Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 205. Spain Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 206. Netherlands Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 207. Switzerland Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 208. Sweden Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 209. Poland Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 210. China Celiac Drugs Revenue by Type (2021-2026) & (US$ Million) Table 211. China Celiac Drugs Revenue by Type (2027-2032) & (US$ Million) Table 212. China Celiac Drugs Sales by Type (2021-2026) & (k units) Table 213. China Celiac Drugs Sales by Type (2027-2032) & (k units) Table 214. China Celiac Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 215. China Celiac Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 216. China Celiac Drugs Revenue by Application (2021-2026) & (US$ Million) Table 217. China Celiac Drugs Revenue by Application (2027-2032) & (US$ Million) Table 218. China Celiac Drugs Sales by Application (2021-2026) & (k units) Table 219. China Celiac Drugs Sales by Application (2027-2032) & (k units) Table 220. China Celiac Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 221. China Celiac Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 222. Asia Celiac Drugs Revenue by Type (2021-2026) & (US$ Million) Table 223. Asia Celiac Drugs Revenue by Type (2027-2032) & (US$ Million) Table 224. Asia Celiac Drugs Sales by Type (2021-2026) & (k units) Table 225. Asia Celiac Drugs Sales by Type (2027-2032) & (k units) Table 226. Asia Celiac Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 227. Asia Celiac Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 228. Asia Celiac Drugs Revenue by Application (2021-2026) & (US$ Million) Table 229. Asia Celiac Drugs Revenue by Application (2027-2032) & (US$ Million) Table 230. Asia Celiac Drugs Sales by Application (2021-2026) & (k units) Table 231. Asia Celiac Drugs Sales by Application (2027-2032) & (k units) Table 232. Asia Celiac Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 233. Asia Celiac Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 234. Asia Celiac Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 235. Asia Celiac Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 236. Asia Celiac Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 237. Asia Celiac Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 238. Asia Celiac Drugs Sales by Country (2021-2026) & (k units) Table 239. Asia Celiac Drugs Sales by Country (2027-2032) & (k units) Table 240. Asia Celiac Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 241. Asia Celiac Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 242. Japan Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 243. South Korea Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 244. India Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 245. Australia Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 246. Taiwan Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 247. Southeast Asia Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 248. SAMEA Celiac Drugs Revenue by Type (2021-2026) & (US$ Million) Table 249. SAMEA Celiac Drugs Revenue by Type (2027-2032) & (US$ Million) Table 250. SAMEA Celiac Drugs Sales by Type (2021-2026) & (k units) Table 251. SAMEA Celiac Drugs Sales by Type (2027-2032) & (k units) Table 252. SAMEA Celiac Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 253. SAMEA Celiac Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 254. SAMEA Celiac Drugs Revenue by Application (2021-2026) & (US$ Million) Table 255. SAMEA Celiac Drugs Revenue by Application (2027-2032) & (US$ Million) Table 256. SAMEA Celiac Drugs Sales by Application (2021-2026) & (k units) Table 257. SAMEA Celiac Drugs Sales by Application (2027-2032) & (k units) Table 258. SAMEA Celiac Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 259. SAMEA Celiac Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 260. SAMEA Celiac Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 261. SAMEA Celiac Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 262. SAMEA Celiac Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 263. SAMEA Celiac Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 264. SAMEA Celiac Drugs Sales by Country (2021-2026) & (k units) Table 265. SAMEA Celiac Drugs Sales by Country (2027-2032) & (k units) Table 266. SAMEA Celiac Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 267. SAMEA Celiac Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 268. Brazil Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 269. Argentina Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 270. Chile Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 271. Colombia Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 272. Peru Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 273. Saudi Arabia Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 274. Israel Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 275. UAE Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 276. Turkey Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 277. Iran Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 278. Egypt Celiac Drugs Revenue (2021-2032) & (US$ Million) Table 279. Key Raw Materials Table 280. Raw Materials Key Suppliers Table 281. Celiac Drugs Distributors List Table 282. Celiac Drugs Customers List Table 283. Research Programs/Design for This Report Table 284. Authors List of This Report Table 285. Secondary Sources Table 286. Primary Sources List of Figures Figure 1. Celiac Drugs Image Figure 2. Global Celiac Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Celiac Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. First Line Of Treatment Image Figure 5. Second Line Of Treatment Image Figure 6. Global Celiac Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Celiac Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Women Image Figure 9. Men Image Figure 10. Children Image Figure 11. Global Celiac Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Celiac Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Celiac Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Celiac Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Celiac Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Celiac Drugs Sales (2021-2032) & (k units) Figure 17. Global Celiac Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Celiac Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Celiac Drugs Sales YoY (2021-2032) & (k units) Figure 20. Europe Celiac Drugs Sales YoY (2021-2032) & (k units) Figure 21. China Celiac Drugs Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Celiac Drugs Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Celiac Drugs Sales YoY (2021-2032) & (k units) Figure 24. Global Celiac Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Celiac Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Celiac Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Celiac Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Celiac Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Celiac Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Celiac Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Celiac Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Celiac Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Celiac Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Celiac Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Celiac Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Celiac Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Celiac Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Celiac Drugs Revenue Share by Type (2021-2032) Figure 40. North America Celiac Drugs Sales Share by Type (2021-2032) Figure 41. North America Celiac Drugs Revenue Share by Application (2021-2032) Figure 42. North America Celiac Drugs Sales Share by Application (2021-2032) Figure 43. North America Celiac Drugs Revenue Share by Country (2021-2032) Figure 44. North America Celiac Drugs Sales Share by Country (2021-2032) Figure 45. Europe Celiac Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Celiac Drugs Sales Share by Type (2021-2032) Figure 47. Europe Celiac Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Celiac Drugs Sales Share by Application (2021-2032) Figure 49. Europe Celiac Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Celiac Drugs Sales Share by Country (2021-2032) Figure 51. China Celiac Drugs Revenue Share by Type (2021-2032) Figure 52. China Celiac Drugs Sales Share by Type (2021-2032) Figure 53. China Celiac Drugs Revenue Share by Application (2021-2032) Figure 54. China Celiac Drugs Sales Share by Application (2021-2032) Figure 55. Asia Celiac Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Celiac Drugs Sales Share by Type (2021-2032) Figure 57. Asia Celiac Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Celiac Drugs Sales Share by Application (2021-2032) Figure 59. Asia Celiac Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Celiac Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Celiac Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Celiac Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Celiac Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Celiac Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Celiac Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Celiac Drugs Sales Share by Country (2021-2032) Figure 67. Celiac Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Celiac Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • First Line Of Treatment
  • Second Line Of Treatment
Applications
  • Women
  • Men
  • Children
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck
  • Biogen
  • Bayer
  • Amgen
  • LFB Group
  • Kedrion Biopharma
  • Innovate Biopharmaceuticals
  • ImmusanT
  • Immunomedics
  • ImmunogenX
  • F Hoffmann-La Roche
  • Celimmune
  • Celgene
  • Bristol-Myers Squibb
  • Biotest
  • BioLineRx
  • Anthera Pharmaceuticals
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Celiac Drugs Market by Type
  3. 1.2.1 Global Celiac Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 First Line Of Treatment
  5. 1.2.3 Second Line Of Treatment
  6. 1.3 Celiac Drugs Market by Application
  7. 1.3.1 Global Celiac Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Women
  9. 1.3.3 Men
  10. 1.3.4 Children
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Celiac Drugs Market Dynamics
  1. 2.1 Celiac Drugs Industry Trends
  2. 2.2 Celiac Drugs Industry Drivers
  3. 2.3 Celiac Drugs Industry Opportunities and Challenges
  4. 2.4 Celiac Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Celiac Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Celiac Drugs Revenue by Region
  3. 3.2.1 Global Celiac Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Celiac Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Celiac Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Celiac Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Celiac Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Celiac Drugs Sales by Region
  9. 3.4.1 Global Celiac Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Celiac Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Celiac Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Celiac Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Celiac Drugs Revenue by Manufacturers
  2. 4.1.1 Global Celiac Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Celiac Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Celiac Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Celiac Drugs Sales by Manufacturers
  6. 4.2.1 Global Celiac Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Celiac Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Celiac Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Celiac Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Celiac Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Celiac Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Celiac Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Celiac Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Celiac Drugs Market CR5 and HHI
  16. 4.8.2 2025 Celiac Drugs Tier 1, Tier 2, and Tier 3
5 Celiac Drugs Market by Type
  1. 5.1 Global Celiac Drugs Revenue by Type
  2. 5.1.1 Global Celiac Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Celiac Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Celiac Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Celiac Drugs Sales by Type
  6. 5.2.1 Global Celiac Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Celiac Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Celiac Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Celiac Drugs Price by Type
6 Celiac Drugs Market by Application
  1. 6.1 Global Celiac Drugs Revenue by Application
  2. 6.1.1 Global Celiac Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Celiac Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Celiac Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Celiac Drugs Sales by Application
  6. 6.2.1 Global Celiac Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Celiac Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Celiac Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Celiac Drugs Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Celiac Drugs Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Celiac Drugs Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Celiac Drugs Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Biogen
  20. 7.4.1 Biogen Company Information
  21. 7.4.2 Biogen Business Overview
  22. 7.4.3 Biogen Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biogen Celiac Drugs Product Portfolio
  24. 7.4.5 Biogen Recent Developments
  25. 7.5 Bayer
  26. 7.5.1 Bayer Company Information
  27. 7.5.2 Bayer Business Overview
  28. 7.5.3 Bayer Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bayer Celiac Drugs Product Portfolio
  30. 7.5.5 Bayer Recent Developments
  31. 7.6 Amgen
  32. 7.6.1 Amgen Company Information
  33. 7.6.2 Amgen Business Overview
  34. 7.6.3 Amgen Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Amgen Celiac Drugs Product Portfolio
  36. 7.6.5 Amgen Recent Developments
  37. 7.7 LFB Group
  38. 7.7.1 LFB Group Company Information
  39. 7.7.2 LFB Group Business Overview
  40. 7.7.3 LFB Group Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 LFB Group Celiac Drugs Product Portfolio
  42. 7.7.5 LFB Group Recent Developments
  43. 7.8 Kedrion Biopharma
  44. 7.8.1 Kedrion Biopharma Company Information
  45. 7.8.2 Kedrion Biopharma Business Overview
  46. 7.8.3 Kedrion Biopharma Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Kedrion Biopharma Celiac Drugs Product Portfolio
  48. 7.8.5 Kedrion Biopharma Recent Developments
  49. 7.9 Innovate Biopharmaceuticals
  50. 7.9.1 Innovate Biopharmaceuticals Company Information
  51. 7.9.2 Innovate Biopharmaceuticals Business Overview
  52. 7.9.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Innovate Biopharmaceuticals Celiac Drugs Product Portfolio
  54. 7.9.5 Innovate Biopharmaceuticals Recent Developments
  55. 7.10 ImmusanT
  56. 7.10.1 ImmusanT Company Information
  57. 7.10.2 ImmusanT Business Overview
  58. 7.10.3 ImmusanT Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 ImmusanT Celiac Drugs Product Portfolio
  60. 7.10.5 ImmusanT Recent Developments
  61. 7.11 Immunomedics
  62. 7.11.1 Immunomedics Company Information
  63. 7.11.2 Immunomedics Business Overview
  64. 7.11.3 Immunomedics Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Immunomedics Celiac Drugs Product Portfolio
  66. 7.11.5 Immunomedics Recent Developments
  67. 7.12 ImmunogenX
  68. 7.12.1 ImmunogenX Company Information
  69. 7.12.2 ImmunogenX Business Overview
  70. 7.12.3 ImmunogenX Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 ImmunogenX Celiac Drugs Product Portfolio
  72. 7.12.5 ImmunogenX Recent Developments
  73. 7.13 F Hoffmann-La Roche
  74. 7.13.1 F Hoffmann-La Roche Company Information
  75. 7.13.2 F Hoffmann-La Roche Business Overview
  76. 7.13.3 F Hoffmann-La Roche Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 F Hoffmann-La Roche Celiac Drugs Product Portfolio
  78. 7.13.5 F Hoffmann-La Roche Recent Developments
  79. 7.14 Celimmune
  80. 7.14.1 Celimmune Company Information
  81. 7.14.2 Celimmune Business Overview
  82. 7.14.3 Celimmune Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Celimmune Celiac Drugs Product Portfolio
  84. 7.14.5 Celimmune Recent Developments
  85. 7.15 Celgene
  86. 7.15.1 Celgene Company Information
  87. 7.15.2 Celgene Business Overview
  88. 7.15.3 Celgene Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Celgene Celiac Drugs Product Portfolio
  90. 7.15.5 Celgene Recent Developments
  91. 7.16 Bristol-Myers Squibb
  92. 7.16.1 Bristol-Myers Squibb Company Information
  93. 7.16.2 Bristol-Myers Squibb Business Overview
  94. 7.16.3 Bristol-Myers Squibb Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Bristol-Myers Squibb Celiac Drugs Product Portfolio
  96. 7.16.5 Bristol-Myers Squibb Recent Developments
  97. 7.17 Biotest
  98. 7.17.1 Biotest Company Information
  99. 7.17.2 Biotest Business Overview
  100. 7.17.3 Biotest Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Biotest Celiac Drugs Product Portfolio
  102. 7.17.5 Biotest Recent Developments
  103. 7.18 BioLineRx
  104. 7.18.1 BioLineRx Company Information
  105. 7.18.2 BioLineRx Business Overview
  106. 7.18.3 BioLineRx Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 BioLineRx Celiac Drugs Product Portfolio
  108. 7.18.5 BioLineRx Recent Developments
  109. 7.19 Anthera Pharmaceuticals
  110. 7.19.1 Anthera Pharmaceuticals Company Information
  111. 7.19.2 Anthera Pharmaceuticals Business Overview
  112. 7.19.3 Anthera Pharmaceuticals Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Anthera Pharmaceuticals Celiac Drugs Product Portfolio
  114. 7.19.5 Anthera Pharmaceuticals Recent Developments
  115. 7.20 ADMA Biologics
  116. 7.20.1 ADMA Biologics Company Information
  117. 7.20.2 ADMA Biologics Business Overview
  118. 7.20.3 ADMA Biologics Celiac Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 ADMA Biologics Celiac Drugs Product Portfolio
  120. 7.20.5 ADMA Biologics Recent Developments
8 North America
  1. 8.1 North America Celiac Drugs Market Size by Type
  2. 8.1.1 North America Celiac Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Celiac Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Celiac Drugs Price by Type (2021-2032)
  5. 8.2 North America Celiac Drugs Market Size by Application
  6. 8.2.1 North America Celiac Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Celiac Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Celiac Drugs Price by Application (2021-2032)
  9. 8.3 North America Celiac Drugs Market Size by Country
  10. 8.3.1 North America Celiac Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Celiac Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Celiac Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Celiac Drugs Market Size by Type
  2. 9.1.1 Europe Celiac Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Celiac Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Celiac Drugs Price by Type (2021-2032)
  5. 9.2 Europe Celiac Drugs Market Size by Application
  6. 9.2.1 Europe Celiac Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Celiac Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Celiac Drugs Price by Application (2021-2032)
  9. 9.3 Europe Celiac Drugs Market Size by Country
  10. 9.3.1 Europe Celiac Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Celiac Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Celiac Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Celiac Drugs Market Size by Type
  2. 10.1.1 China Celiac Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Celiac Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Celiac Drugs Price by Type (2021-2032)
  5. 10.2 China Celiac Drugs Market Size by Application
  6. 10.2.1 China Celiac Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Celiac Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Celiac Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Celiac Drugs Market Size by Type
  2. 11.1.1 Asia Celiac Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Celiac Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Celiac Drugs Price by Type (2021-2032)
  5. 11.2 Asia Celiac Drugs Market Size by Application
  6. 11.2.1 Asia Celiac Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Celiac Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Celiac Drugs Price by Application (2021-2032)
  9. 11.3 Asia Celiac Drugs Market Size by Country
  10. 11.3.1 Asia Celiac Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Celiac Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Celiac Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Celiac Drugs Market Size by Type
  2. 12.1.1 SAMEA Celiac Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Celiac Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Celiac Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Celiac Drugs Market Size by Application
  6. 12.2.1 SAMEA Celiac Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Celiac Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Celiac Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Celiac Drugs Market Size by Country
  10. 12.3.1 SAMEA Celiac Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Celiac Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Celiac Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Celiac Drugs Value Chain Analysis
  2. 13.1.1 Celiac Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Celiac Drugs Production Mode & Process
  6. 13.2 Celiac Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Celiac Drugs Distributors
  9. 13.2.3 Celiac Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst